Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticlePediatric Rheumatology

Recent Trends in Medication Usage for the Treatment of Juvenile Idiopathic Arthritis and the Influence of Tumor Necrosis Factor Inhibitors

Melissa L. Mannion, Fenglong Xie, Jeffrey R. Curtis and Timothy Beukelman
The Journal of Rheumatology October 2014, 41 (10) 2078-2084; DOI: https://doi.org/10.3899/jrheum.140012
Melissa L. Mannion
From the Department of Pediatrics, Department of Medicine, and the Division of Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fenglong Xie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey R. Curtis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy Beukelman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tbeukelman@peds.uab.edu
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 41 no. 10 2078-2084
DOI 
https://doi.org/10.3899/jrheum.140012
PubMed 
25086081

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication May 15, 2014
  • Published online October 1, 2014.

Article Versions

  • Latest version (August 1, 2014 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2014

Author Information

  1. Melissa L. Mannion,
  2. Fenglong Xie,
  3. Jeffrey R. Curtis and
  4. Timothy Beukelman⇑
  1. From the Department of Pediatrics, Department of Medicine, and the Division of Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  2. M.L. Mannion, MD, Pediatric Rheumatology Fellow; T. Beukelman, MD, MSCE, Associate Professor, Department of Pediatrics, and the Division of Rheumatology; F. Xie, MS; J.R. Curtis, MD, MS, MPH, Associate Professor, Department of Medicine, and the Division of Rheumatology, University of Alabama at Birmingham.
  1. Address correspondence to Dr. T. Beukelman, University of Alabama at Birmingham, CPP 210, 1600 7th Ave. S., Birmingham, Alabama 35233, USA. E-mail: tbeukelman{at}peds.uab.edu

Article usage

Article usage: July 2014 to April 2022

AbstractFullPdf
Jul 2014201
Aug 2014256052
Sep 2014118418
Oct 20146002257
Nov 201499819
Dec 201452212
Jan 201548616
Feb 20153402
Mar 20152836
Apr 20153713
May 20151812
Jun 20152845
Jul 20152233
Aug 20152337
Sep 20151002
Oct 20151512
Nov 20151956
Dec 20151611
Jan 20164033
Feb 20161722
Mar 20161622
Apr 20163103
May 20161343
Jun 20161432
Jul 20161302
Aug 20161133
Sep 20162826
Oct 20161031
Nov 2016612
Dec 20164004
Jan 20171010
Feb 20172042
Mar 20171621
Apr 20171720
May 20172100
Jun 20171952
Jul 20171022
Aug 20171721
Sep 20171211
Oct 20171512
Nov 20173200
Dec 20171311
Jan 20181000
Feb 20181401
Mar 20181700
Apr 20182221
May 20181652
Jun 2018900
Jul 20182201
Aug 2018922
Sep 20181411
Oct 20181751
Nov 20181411
Dec 20181731
Jan 20192053
Feb 20192332
Mar 20191031
Apr 20191300
May 2019710
Jun 201918911
Jul 20191520
Aug 20191541
Sep 20191221
Oct 20192432
Nov 20191542
Dec 20191210
Jan 2020921
Feb 20200123
Mar 20200106
Apr 20201114
May 20203144
Jun 2020866
Jul 20202811
Aug 20206513
Sep 2020284
Oct 202052511
Nov 2020247
Dec 20203115
Jan 20211410
Feb 20217239
Mar 2021175
Apr 2021474
May 20213735
Jun 2021064
Jul 2021031
Aug 2021131
Sep 2021456
Oct 20214820
Nov 20211013
Dec 20211165
Jan 2022134
Feb 2022262
Mar 20221276
Apr 20221797

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 10
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Recent Trends in Medication Usage for the Treatment of Juvenile Idiopathic Arthritis and the Influence of Tumor Necrosis Factor Inhibitors
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Recent Trends in Medication Usage for the Treatment of Juvenile Idiopathic Arthritis and the Influence of Tumor Necrosis Factor Inhibitors
Melissa L. Mannion, Fenglong Xie, Jeffrey R. Curtis, Timothy Beukelman
The Journal of Rheumatology Oct 2014, 41 (10) 2078-2084; DOI: 10.3899/jrheum.140012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Recent Trends in Medication Usage for the Treatment of Juvenile Idiopathic Arthritis and the Influence of Tumor Necrosis Factor Inhibitors
Melissa L. Mannion, Fenglong Xie, Jeffrey R. Curtis, Timothy Beukelman
The Journal of Rheumatology Oct 2014, 41 (10) 2078-2084; DOI: 10.3899/jrheum.140012
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

JUVENILE IDIOPATHIC ARTHRITIS
METHOTREXATE
TUMOR NECROSIS FACTOR INHIBITORS

Related Articles

Cited By...

More in this TOC Section

  • Profiling Behavioral and Psychological Symptoms in Children Undergoing Treatment for Spondyloarthritis and Polyarthritis
  • Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference
  • Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry
Show more Pediatric Rheumatology

Similar Articles

Keywords

  • juvenile idiopathic arthritis
  • methotrexate
  • tumor necrosis factor inhibitors

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire